Soluble CD163, CXCL5, and blood cell counts, including absolute lymphocyte and eosinophil counts, were identified as predictors of irAEs in melanoma, renal cell carcinoma (RCC), and urothelial carcinoma [230, 231]. The gene discussed is CXCL5; the disease is renal cell carcinoma.